Latest news
Travere Therapeutics (TVTX) On Q2 Results And FILSPARI Hopes As Fair Value Stays In View - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 04:29:00 GMTLigand Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:19:22 GMTTravere Therapeutics (TVTX) Stock Climbs On FILSPARI Momentum As Losses Deepen - SahmSahm · Thu, 06 Aug 2026 07:00:00 GMTTravere Therapeutics: Buy Rating Reiterated as FILSPARI Momentum Builds and Key Catalysts Approach; Price Target Unchanged at $67 - TipRanksTipRanks · Wed, 05 Aug 2026 10:36:50 GMTTravere Stock Sinks Despite Bullish Kidney Drug Momentum - TipRanksTipRanks · Tue, 04 Aug 2026 21:13:46 GMTTravere Therapeutics Reports Second Quarter 2026 Financial Results - Business WireBusiness Wire · Tue, 04 Aug 2026 20:01:00 GMT